ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS. Mediterr J Hematol Infect Dis 2012, 4 (1), e2012072. https://doi.org/10.4084/mjhid.2012.072.